PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.\', \'Department of Strategy Development, Ministry of Health, Republic of Turkey, Ankara, Turkey.\', \'Department of Hematology, Kayseri City Hospital, University of Health Sciences, Kayseri, Turkey.\', \'Department of Hematology, Bozyaka Training and Research Hospital, University of Health Sciences, Izmir, Turkey.\', \'Division of Hematology, Department of Internal Medicine, School of Medicine, Selçuk University, Konya, Turkey.\', \'Division of Hematology, Department of Internal Medicine, School of Medicine, Sakarya University, Sakarya, Turkey.\', \'Department of Hematology, İstanbul Training and Research Hospital, İstanbul, Turkey.\', \'Division of Hematology, Department of Internal Medicine, School of Medicine, İnönü University, Malatya, Turkey.\', \'Department of Internal Medicine, Keçiören Training and Research Hospital, Ankara, Turkey.\', \'Division of Hematology, Department of Internal Medicine, School of Medicine, Namık Kemal University, Tekirdağ, Turkey.\', \'Ankara Provincial Health Directorate, Ministry of Health, Republic of Turkey, Ankara, Turkey.\', \'General Directorate of Health Information Systems, Ministry of Health, Republic of Turkey, Ankara, Turkey.\', \'Public Hospitals General Directorate, Ministry of Health, Republic of Turkey, Ankara, Turkey.\', \'Deputy Minister of Health, Republic of Turkey, Ankara, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/1078155220953198
?:doi
?:hasPublicationType
?:journal
  • Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
is ?:pmid of
?:pmid
?:pmid
  • 32854573
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32854573>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32854573>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all